Detalles de la búsqueda
1.
A novel influenza A (H1N1) vaccine in various age groups.
N Engl J Med
; 361(25): 2414-23, 2009 Dec 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-19846844
2.
Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial.
Lancet
; 375(9708): 56-66, 2010 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-20018364
3.
A rapid immune response to 2009 influenza A(H1N1) vaccines in adults: a randomized, double-blind, controlled trial.
J Infect Dis
; 202(5): 675-80, 2010 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20632888
4.
Immunogenicity, safety, and cross-reactivity of an inactivated, adjuvanted, prototype pandemic influenza (H5N1) vaccine: a phase II, double-blind, randomized trial.
Clin Infect Dis
; 48(8): 1087-95, 2009 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19281330
5.
[Effectiveness of inactivated poliomyelitis vaccine for primary vaccination].
Zhonghua Yu Fang Yi Xue Za Zhi
; 43(6): 501-3, 2009 Jun.
Artículo
en Zh
| MEDLINE | ID: mdl-19950717
6.
Antibody persistence at 18-20 months of age and safety and immunogenicity of a booster dose of a combined DTaP-IPV//PRPâ¼T vaccine compared to separate vaccines (DTaP, PRPâ¼T and IPV) following primary vaccination of healthy infants in the People's Republic of China.
Vaccine
; 29(50): 9337-44, 2011 Nov 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-22001281
7.
[Immunogenicity and safety of DTaP-IPV//PRP-T combined vaccine in infants in China].
Zhonghua Liu Xing Bing Xue Za Zhi
; 32(8): 808-15, 2011 Aug.
Artículo
en Zh
| MEDLINE | ID: mdl-22093474
8.
Immunogenicity and safety of a pentavalent acellular pertussis combined vaccine including diphtheria, tetanus, inactivated poliovirus and conjugated Haemophilus Influenzae type b polysaccharide for primary vaccination at 2, 3, 4 or 3, 4, 5 months of age in infants in China.
Vaccine
; 29(10): 1913-20, 2011 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-21219984
9.
Safety and immunogenicity of adjuvanted inactivated split-virion and whole-virion influenza A (H5N1) vaccines in children: a phase I-II randomized trial.
Vaccine
; 28(38): 6221-7, 2010 Aug 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-20638454
10.
[Analysis and evaluation on quality of live attenuated measles vaccine from market surveillance sampling].
Zhongguo Yi Miao He Mian Yi
; 15(6): 511-5, 2009 Dec.
Artículo
en Zh
| MEDLINE | ID: mdl-20518326
11.
Antibody persistence after 2-dose priming and booster response to a third dose of an inactivated, adjuvanted, whole-virion H5N1 vaccine.
J Infect Dis
; 199(2): 184-7, 2009 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19067606
12.
[Study on the safety and immunogenicity of MF59-adjuvanted influenza subunit vaccine in Chinese elderly].
Zhonghua Liu Xing Bing Xue Za Zhi
; 29(6): 548-51, 2008 Jun.
Artículo
en Zh
| MEDLINE | ID: mdl-19040034
13.
[Evaluation on the safety and immunogenicity of Canada split influenza virus vaccine].
Zhonghua Liu Xing Bing Xue Za Zhi
; 26(7): 503-6, 2005 Jul.
Artículo
en Zh
| MEDLINE | ID: mdl-16335001
14.
[Safety and immunogenicity of split vaccines of influenza viruses].
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi
; 18(3): 207-9, 2004 Sep.
Artículo
en Zh
| MEDLINE | ID: mdl-15640848
15.
[Analysis of influenza antibodies in normal people in Jiangsu Province in 2003 ].
Zhonghua Liu Xing Bing Xue Za Zhi
; 25(11): 1008, 2004 Nov.
Artículo
en Zh
| MEDLINE | ID: mdl-15769348
Resultados
1 -
15
de 15
1
Próxima >
>>